African Journal of Traditional, Complementary and Alternative Medicines African Ethnomedicines Network ISSN: 0189-6016 Vol. 4, Num. 1, 2007, pp. 99-106

African Journal of Traditional, Complimentary and Alternative Medicines,, Vol.4, No. 1, 2007, pg. 99-106

RESEARCH PAPER

POTENTIAL OF NEUROPROTECTIVE ANTIOXIDANT-BASED THERAPEUTICS FROM PELTOPHORUM AFRICANUM SOND.(FABACEAE)

E. S. Bizimenyera*^a,b, M. A. Aderogba ^a, J. N. Eloff ^a, and G. E. Swan ^a

^a Programme for Phytomedicine, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.
^b Department of Veterinary Medicine, Makerere University, P O Box 7062, Kampala, Uganda.
* Corresponding author: Tel. +27781677665; Fax: +2712-529-8304; E-mail: ebizimenyera@yahoo.co.uk

Code Number: tc07005

Abstract

There is ample scientific and empirical evidence supporting the use of plant-derived antioxidants for the control of neurodegenerative disorders. Antioxidants may have neuroprotective (preventing apoptosis) and neuroregenerative roles, by reducing or reversing cellular damage and by slowing progression of neuronal cell loss. Although demand for phytotherapeutic agents is growing, there is need for their scientific validation before plant-derived extracts gain wider acceptance and use. We have evaluated antioxidant potential of Peltophorum africanum (weeping wattle), a plant widespread in the tropics and traditionally used, inter alia, for the relief of acute and chronic pain, anxiety and depression. The dried leaves, bark and root of P. africanum were extracted with acetone. Thin layer chromatograms were sprayed with 0.2% 2,2-diphenyl-1-picryl hydrazyl (DPPH) in methanol for screening for antioxidants. Quantification of antioxidant activity was assessed against 6-hydroxy-2, 5,7,8-tetramethylchromane-2-carboxylic acid (Trolox) and L-ascorbic acid (both standard antioxidants), using two free radicals, 2,2´-azinobis (3-ethyl-benzothiazoline-6-sulfonic acid) (ABTS) and DPPH, respectively. Results of our study show that the bark and root extracts had higher antioxidant activity than L-ascorbic acid and Trolox, a synthetic vitamin-E analogue. The respective TEAC (Trolox Equivalent Antioxidant Capacity) values for the bark and root extracts, and Trolox were 1.08, 1.28 and 1.0. EC₅₀ values for L-ascorbic acid (5.04 µg/mL) was more active than the leaf 6.54 (µg/mL), but much less active than the bark (4.37 µg/mL) and root (3.82 µg/mL) extracts. Continued work on P. africanum, and other plants rich in antioxidants, may avail neuroscientists with potent neuroprotective antioxidant therapeutics.

Key words: Antioxidant; Extracts; Neurodegeneration; Neuroprotection; Oxidative stress; Peltophorum africanum

Introduction

Oxidative stress is the result of an imbalance in the pro-oxidant/antioxidant homeostasis leading to the generation of excess reactive oxygen species (ROS), implicated inter alia in the cause of carcinogenetic, inflammatory, infectious, cardiovascular and neurological diseases in man and animals (Nair et al., 2003). Under normal conditions, the body is equipped with defense mechanisms that scavenge ROS and protect the cells from oxidative damage. However, the detoxifying enzyme processes get overwhelmed, saturated, and faulty under conditions of low dietary antioxidant intake, inflammation, aging or exposure to environmental factors such as irradiation or tobacco smoke, inducing some enzymes like cyclooxygenase-2 (COX-2), lipoxygenase (LOX) and inducible nitric acid synthase (iNOS) that generate intermediaries that damage cellular macromolecules including DNA (Floyd, 1999; Rao and Balachandran, 2000; Nair et al., 2003). The damage is made on proteins, lipids, and nucleic acids signaling cascades leading to disruption of ion homeostasis and modification of the genetic apparatus, with consequence of apoptotic cell death (Sun and Chen, 1998; Sing et al., 2004). The brain is in particular very sensitive to oxidation stress possibly because of its high lipid content, high aerobic metabolic activity and low catalase activity (Halliwell and Gutteridge, 1985; Cao et al., 1988; Floyd and Carney, 1992; Gilgun-Sherki et al., 2001.

Antioxidants (AOX) are considered a promising therapeutic approach as they may be playing neuroprotective (preventing apoptosis) and neuroregenerative roles (Moosmann and Behl, 2002). Plant-derived antioxidants offer prospects in this regard. In nature, AOX are grouped as endogenous or exogenous. The endogenous group includes enzymes (and trace elements part-of) like superoxidase dismutase (zinc, manganese, and copper), glutathione peroxide (selenium) and catalase, and proteins like albumin, transferrin, ceruloplasmin, metallothionein and haptoglobin. The most important exogenous AOX are dietary phytochemicals (such as polyphenols, quinones, flavonoids, catechins, coumarins, terpenoids) and the smaller molecules like ascorbic acid (Vitamin C), alpha-tocopherol (Vitamin E) and beta-carotene vitamin-E, and supplements. The antioxidant processes occur in cytosol, mitochondria or in plasma (Larson 1988; Namiki et al., 1993; Berger, 2005). Though their mode of action is not yet completely elucidated, and clinical trials involving them are still relatively scarce, AOX offer a promising approach in the control or slowing down progression of neurodegenerative disorders such as Alzheimer"s disease, Parkinson"s disease, Huntington"s disease, amyotrophic lateral sclerosis and ischaemic and haemorrhagic stroke (Maxwell, 1995; Floyd, 1999; Mattson, 2000; Moosmann and Behl, 2002; Nair et al., 2003; Berger, 2005). To write off antioxidants as potentially harmful, is ultimately keeping a potential weapon out of the therapeutic arsenal. Strategies aimed at limiting ROS oxidative stress damage, may slow the progression of neurodegenerative diseases (Halliwell, 2001; Singh et al., 2004). Since endogenous AOX defences are not always completely effective, and since exposure to damaging environmental factors is increasing, exogenous AOX will find more roles in diminishing the cumulative effects of oxidative damage (Gilgun-Sherki et al., 2001). Plant derived AOX are regarded as effective in controlling the effects of oxidative damage, and hence have had influence in what people eat and drink (Viana et al., 1996; Sun et al., 2002; Pinder and Sandler, 2004). As the focus of medicine shifts from treatment of manifest disease to prevention, herbal medicine (with its four pillars of phytochemistry, phytopharmacy, phytopharmacology and phytotherapy) is coming into consideration, being a renaissance of age-old human tradition (Weiss and Fintelmann, 2000). The "Green"movement in Western society has changed attitudes in the general population who now conceive naturally derived substances and extracts as being inherently safer and more desirable than synthetic chemicals products, with the net effect of increase in sales of herbal preparations (Houghton and Raman, 1998; Capasso et al., 2000). About 80% of people in the developing world rely on phytomedicine for primary healthcare for man and livestock (Plotkin, 1992; McCorkle et al., 1996).

However, despite the demand of phytotherapeutic agents growing (Capasso et al., 2000), most medical and veterinary professionals still distrust the use of herbal medicines, due to lack of scientific evidence of efficacy and safety (Sofowora, 1982; Thompson, 1997). Hence the need for their scientific validation before plant-derived extracts gain wider acceptance and use. In this regard, many plants nevertheless have been scientifically proved to be effective in control of acute and chronic nervous disorders (Table 1). As herbal extracts are a complex mixture of compounds, the active molecules, mode of action, bioavailability and pharmacokinetics, and toxicity issues become difficult to evaluate.

Peltophorum africanum (weeping wattle), a plant widespread in southern Africa and most tropical areas, is unique in that it is traditionally used to treat more less similar disease conditions in man and domesticated animals. The root and bark decoctions are used to treat wounds, colic (acute pains), joint and back pain (chronic pains), ascites and abdominal disorders, diarrhoea and dysentery, infertility, and depression (Watt and Breyer-Brandwijk, 1962; Venter and Venter, 1996; Van Wyk and Geriche, 2000; Manana, 2003). In southern Africa, women who lose their spouses take the bark/root decoctions for up to a year, possibly for relief of post-traumatic stress. In livestock, the plant is used against diarrhoea, dysentery, colic and as a general tonic. Pastoralists use root as a component in the "Kgatla doctors" mixture to promote well-being, resistance to diseases and fertility (Watt and Breyer-Brandwijk, 1962; Cunningham and Zondi, 1991; Van der Merwe, 2000). From the foregoing, the traditional use point to P. africanum as having antibacterial, anthelmintic, anti-inflammatory and antioxidant activities. Most of the compounds isolated by phytochemists are polyphenols, typical of antioxidants of higher plants (Larson, 1988; Paya et al., 1992; Braca et al., 2002). It is not surprising therefore, that Bizimenyera et al. (2005), reported high concentrations (20-50%) of polyphenols in the extracts of P. africanum .

Hence, P. africanum could have potential for neuroprotective antioxidant-based thera-peutics. In the study described hereafter, the comparative antioxidant activity potential of P. africanum extracts was assessed against 6-hydroxy-2, 5,7,8-tetramethylchromane-2-carboxylic acid (Trolox) and L-ascorbic acid ( both standard antioxidants), using two free radicals, 2,2´-azinobis (3-ethyl-benzothiazoline-6-sulfonic acid) (ABTS) and 2, 2-diphenyl-1-picryl hydrazyl (DPPH) , respectively.

Methodology

Collection, storage and preparation of plant material

Chemicals

All chemicals used were of analytical grade. L-ascorbic acid (Merck), potassium persulphate (Sigma), 2,2´-azinobis (3-ethyl-benzothiazoline-6-sulfonic acid) (ABTS) (Sigma), 6-hydroxy-2, 5,7,8-tetramethylchromane-2-carboxylic acid (Trolox^®) (Fluka), 2,2-diphenyl-1-picryl hydrazyl (DPPH) (Sigma) and absolute ethanol (Merck).

Evaluation of antioxidant activity

Qualitative screening for antioxidant activity was done using 2, 2-diphenyl-1-picryl hydrazyl (DPPH) according to Takao et al. (1994). Thin layer chromatograms (TLC) of extracts developed in EMW (ethyl acetate /methanol/water (10/1.35 /1) solvent system were sprayed with 0.2% DPPH in methanol. Antioxidant activity is detected on the chromatogram when the initially purple DPPH background turns yellow in bands where an antioxidant is present (Bors et al., 1992).

Quantification of AOX activity was determined spectrophotometrically using two radicals, ABTS and DPPH and the Versa-max^® microplate reader (Labotec). In one method, use was made of theTrolox equivalent antioxidant capacity (TEAC) assay (Re et al., 1999) based on the scavenging of the ABTS radical into a colourless product. The absorbance was read at 734 nm. This method was also used in a previous analysis (Bizimenyera et al., 2005). Trolox (6-hydroxy-2, 5,7,8-tetramethylchromane-2-carboxylic acid) is a Vitamin-E analogue. If an extract had antioxidant activity equivalent to Trolox, its TEAC value would be 1 and if the extract were more active its TEAC would be greater than 1.

The second method described by Mensor et al. (2001), employed the DPPH free radical assay. Different concentrations of the extracts were prepared between 20.0 and 1.0 µg/ml. Ten µL of 0.4 mM DPPH in ethanol was added to 25 µL of each concentration of extract tested and allowed to react at room temperature in the dark for 30 minutes. Blank solutions were prepared with each test sample solution (25 µL) and 10 µL ethanol only while the negative control was DPPH solution, 10 µL plus 25 µL ethanol. L-ascorbic acid was the positive control. The decrease in absorbance was measured at 518 nm. Values obtained were converted to percentage antioxidant activity (AOXA%) using the formula: -

AOXA% = 100 - {[(Abs_sample -Abs_blank) x 100] / Abs _control}

Abs_sample is the absorbance of the sample, Abs_blank is the absorbance of the blank and Abs_control is the absorbance of the control.

L-ascorbic acid (vitamin C) was used as a positive control (antioxidant agent). The antioxidant activity is expressed as effective concentration (EC₅₀) values. The lower the EC₅₀ value, the more effective antioxidant activity. The EC₅₀ value, defined as the concentration of the sample leading to 50% reduction of the initial DPPH concentration, was calculated from the linear regression of plots of concentration of the test extracts (µg/mL) against the mean percentage of the antioxidant activity obtained from three replicate assays. For statistical analysis, the results were expressed as mean ± SEM (standard error of mean) and the EC₅₀ values obtained from the regression plots (SigmaPlots^R 2001, SPSS Science) showed a good coefficient of determination, with most values being r² ≥ 0.910.

Results

All the extracts (leaf, bark and root), from qualitative screening, contained compounds that exhibited considerable free radical scavenging activity, as shown by the yellow bands (of antioxidant activity) on DPPH chromatograms, Figure 1. The root and bark had more antioxidant activity compared to the leaf. The antioxidant activity of the root and bark extracts was higher than both L-ascorbic acid and Trolox (Table 2). The bark and root extracts had higher TEAC values than Trolox (Vitamin-E analogue), with respective values of 1.08, 1.28 and 1.0. L-ascorbic acid (5.04 µg/mL) was more active than the leaf 6.54 (µg/mL), but much less active than the bark (4.37 µg/mL) and root (3.82 µg/mL) extracts (the higher the µg/mL value, the less AOX activity).

Discussion and conclusion

Laboratory results showed the extracts had high levels of antioxidant compounds, especially the root and bark extracts. Both Trolox and L-ascorbic acid have been used as standards in quantifications of antioxidant activity (Van den Berg et al., 1999; Fukomoto and Mazza, 2000). The EC₅₀ of the root (3.82 µg/ml) and bark (4.37 µg/ml) extracts indicated higher antioxidant activity than L-ascorbic acid (5.04 µg/ml), and more effective than Ginkgo biloba extract (EGb 761) whose EC₅₀ is 40.72 µg/mL (Mensor et al., 2001; Bridi et al., 2001; Aderogba et al., 2004). The standardised extract of Ginkgo biloba (EGb 761) has been widely employed for its significant benefit in neurodegenerative disorders (Bridi et al., 2001).

The antioxidant activity in plants may largely be due to polyphenols (Thabrew et al., 1998), and in particular polyphenols make up nearly 50% of P. africanum root and bark extracts (Bizimenyera et al., 2005). The presence of antioxidant compounds also agrees with the phytochemical analyses by other investigators (El Sherbeiny et al., 1977; Evans et al., 1985; Bam et al., 1988 and 1990; Khattab and Nasser, 1998; Mebe and Makuhunga, 1992) who isolated flavonoids, coumarins, gallic acid and other polyphenols from P. africanum extracts.

The root and bark appear to have the highest concentrations of the AOX. Coincidentally, traditional healers also use the root and bark concoctions (Watt and Breyer-Brandwijk, 1962; Cunningham and Zondi , 1991; Venter and Venter, 1996; Van der Merwe, 2000; Van Wyk and Geriche, 2000; Manana, 2003). In all the traditional treatments, decoctions and infusions are made from the root or bark. That is why the present authors believe the rationale for traditional healers using P. africanum in treating inflammation, pain and depression may be due to high AOX compounds present in the plant.

Various chronic degenerative diseases with different clinical appearances appear to share common biochemical, genetic and cellular alterations that are related to disease pathogenesis (Nair et al., 2003; Barnharm et al., 2004). Empirical evidence suggest P. africanum, due to its with its high AOX activity, could be influential in the control of these conditions. Mixtures of dietary antioxidants or foods rich in antioxidants have been shown to increase the ability of lymphocytes to withstand DNA oxidation (Duthie et al., 1996; Pool-Zobel et al., 1997; Porrini and Riso, 2000). Diets rich in flavonoids appear to be protective against ischemic heart disease (Hertog et al., 1993; Viana et al., 1996; Berger, 2005) and supplementing diets with antioxidants generally appears preventing occurrence and progression of many neurodegenerative diseases (Rice-Evans and Diplock, 1993; Rice-Evans et al., 1995; Singh et al., 2004).

The safety of P. africanum extracts still has to be confirmed. From inquiries from pastoralists (Van der Merwe, 2000) and Pretoria market vendors of traditional herbs, P. africanum extracts were reported safe. Tests in our laboratory involving acetone extracts on monkey kidney cells and brine shrimp (awaiting publication) showed no toxicity effects. Bessong et al. (2005) reported no toxicity of the extracts. This, however, is no cause for complacency, as toxicity of herbal medicines has been reported (Capasso et al., 2000).

This paper reports P. africanum leaf, bark and root extracts as showing considerable antioxidant activity. The root and bark had more antioxidants than the leaf. The antioxidant activity of the root and bark extracts, was higher than L-ascorbic acid (Vitamin-C) and Vitamin-E equivalent (Trolox), both standard antioxidants. The results of these in vitro tests would appear to justify the traditional use of the plant in treatment of acute and chronic nervous disorders. Antioxidants appear to have neuroprotective and neurodegenerative roles, reducing or slowing down neuronal cell death, and have an important role to play in diminishing the cumulative effects of oxidative damage. Further in vivo research, and clinical trials are required for generation of conclusive data for use of the plant in treating neurodegenerative diseases. Continued work on plants like P. africanum, rich in antioxidants, may avail medicine with antioxidant-based neuroprotective therapeutics.

Acknowledgements

Staff Development Programme Makerere University, Uganda, the National Research Foundation, South Africa, and the University of Pretoria funded this work

References

1. Aderogba, M .A., Okoh, E. K., Adelanwa, T. A. and Obuotor, E. M. (2004). Antioxidant properties of the Nigerian Piliostigma species. J. Biol. Sci., 4: 501-503
2. Bam M., Ferreira D. and Brandt E. (1988). Novel cyanomaclurin analogue from Peltophorum africa-num, Phytochemistry, 27: 3704-3705.
3. Bam M, Malan J. C. S, Young D. A., Brandt E. V. and Ferreira . (1990). Profisetinidin-type 4-arylflavin-3-ols and related δ-lactones. Phytochemistry, 29: 283-287.
4. Barnham K. J., Masters . L. and Bush A. I. (2004). Neurodegenerative diseases and oxidative stress. Nature Rev. Drug Disc., 3:205-214
5. Berger M. M. (2005). Can oxidative damage be treated nutritionally? Clinical Nutrition, 24:172-183.
6. Bessong P. O., Obi C. L., Andréola M., Rojas B., Pouységu L., Igumbor E., Meyer J. J. M., Quideau S. and Litvak S. ( 2005). Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase. J. Ethnopharmacol, 99:83-91.
7. Bizimenyera E. S., Swan G. E., Chikoto H and Eloff J.N. ( 2005). Rationale for using Peltophorum africanum (Fabaceae) extracts in veterinary medicine. J. S. Afri. Vet. Assoc., 76:54-58.
8. Bors W., Saran .and Eltsner E. .F (1992). Screening of plant antioxidants. Modern Methods of Plant Analysis, 13:277-295
9. Braca A. , Sortino C., Politi M., Morelli. and Mendez J. (2002). Antioxidant activity of flavonoids from Licania licaniaeflora. J. Ethnopharmacol, 79:379-381.
10. Bridi R., Crossetti F. P., Steffen V. M. and Henriques A. T. (2001). The antioxidant activity of standardised extracts of Ginkgo biloba (EGb 761) in rats. Phytother. Res., 15:449-451
11. Cao W., Carney J. M., Duchon A., Floyd R. A. and Chevion M (198). Oxygen free radicals involvement in ischemia and repurfusion injury to brain. Neurosci Lett, 88:233-238.
12. Capasso R., Izzo A. A., Pinto L., Bifulco T., Vitobello C. and Mascolo N. (2000) . Phytotherapy and quality of herbal medicines. Fitoterapia, 71:S58-S65.
13. Cunningham A. B. and Zondi A. S. (1991). Cattle owners and traditional medicines used for livestock. Investigational Report No 69, pg 35. Institute of Natural Resourses, University of Natal. Petermaritzburg.
14. Duthie S. J, Ma A., Ross M. A. and Collins A. R. (1996). Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res, 56:1291-1295
15. Eloff J. N. (1998). Which extractant should be used for the screening and isolation of antimicrobial components from plants? J. Ethnopharmacol, 60: 1-8.
16. El Sherbeiny A. E. A., El Ansari, Nawwar M. A. M and El Sayed N. H. (1977). Flavonol glycosides and flavonol glucoside gallates from Peltophorum africanum. Planta Medica, 32:165-170
17. Evans S. V., Shing T. K. M., Aplin R. T., Fellows L. E. and Fleet G. W .J. (1985). Sulphate ester of trans-4-hydroxypipecolic acid in seeds of Peltophorum. Phytochemistry, 24: 2593-2596.
18. Floyd R. A. (1999). Antioxidants, oxidative stress, and degenerative neurological disorders. Proceedings of the Society for Experimental Biology and Medicine, 222:236-245.
19. Floyd R. A. and Carney J. M. (1992). Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol, 32:S22-S27.
20. Fukumoto L. R., Mazza G. (2000). Assessing antioxidant and prooxidant activities of phenolic compounds. J. Agric. Food Chem., 48: 3597-3604
21. Gilgun-Sherki Y., Melamed E. and Offen D. (2001). Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacol., 40:959-975
22. Halliwell B. and Gutteridge J. M. C. (1985). Oxygen radicals and the nervous system. Trends Neurosci, 8:22-26.
23. Halliwell B. (2001). Role of free radicals in neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs & Aging, 18:685-716.
24. Hertog M. G. L., Feskens E. J. M. and Hollmann .P C. H. (1993). Dietary antioxidant flavonoids and risk of coronary heart disease: the Zuphen Elderly Study. Lancet, 342:1007-1011
25. Houghton P.J. and Raman A. (1998) . Laboratory handbook for the fractionation of natural extracts. Chapman & Hall.London, pg 1-7.
26. Khattab A. M. and Nassar M. I. (1998) . Phytochemical and molluscidal studies on Peltophorum africanum and Sesbania sesbani. Bull. Natl.Res.Cent, Egypt, 23:401-407
27. Larson R. A. (1988). The antioxidants of higher plants. Phytochemistry, 27:969-978.
28. Manana J. V. (2003). Identification of commonly used traditional medicines by planar chromatography for quality control purpose. M.Sc. Dissertation. University of Pretoria, South Africa.
29. Mattson M. P. (2000). Apoptosis in neurodegenerative disorders. Nature Rev. Mol. Cell Biol., 1:120-130
30. Maxwell S. R. J (1995). Prospects for the use of antioxidant therapies. Drugs, 49:345-361.
31. McCorkle C. M., Mathias-Mundy E. and Schillhorn van Veen T. W. (1996). In: Ethnoveterinary Research and Development. Intermediate technology publications.London.
32. Mebe P. P. and Makuhunga P. (1992). 11-(E)-p-coumaric acid ester of bergenin from Peltophorum africanum. Phytochemistry, 31: 3286-3287.
33. Mensor L. L., Menezes F. S., Leitao G. G., Reis A. S., Santos T. C., Coube C. S. and Leitao S. G.. (2001). Screening of Brazilian plants for antioxidant activity by use of DPPH free radical method. Phytother. Res., 15:127-130
34. Moosmann B. and Behl C. (2002). Antioxidants as treatment for neurodegenerative disorders. Expert Opinion on Investigational Drugs, 11:1407-1435.
35. Nair U., Bartsch H. and Nair J. (2003). Prevention of degehnerative diseases; clues from studies investigating oxidative stress, Brussels,13 November 2002. Mutagenesis, 18:477-483.
36. Namiki M., Yamashita K. and Osawa . (!993). Food-related antioxidants and their activities in vivo. In: Active oxygen, lipid peroxidases and antioxidants. Japan Science Society Press, pg. 319-332. Tokyo.
37. Paya M., Halliwell B. and Hoult J. R. S. (1992). Interaction of a series of coumarins with reactive oxygen species. Biochem. Pharmacol, 44: 205 -214.
38. Plotkin M. J. (1992). Ethnomedicine: past, present and future. In: Natural resources and human health: plants of medicinal and nutritional value. Proceedings, pg 79-86. Elsevier, Amsterdam.
39. Pinder R. M. and Sandler M. (2004). Alcohol, wine and mental health: focus on dementia and stroke. J. Psychopharm., 18:449-456.
40. Pool-Zobel B. L., Bub A., Muller H., Wollowski I. and Rechkemmer G (1997). Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis,18:1847-1850.
41. Porrini M. and Riso P. (2000). Lymphocyte lycopene concentration and DNA protection from oxidative damage is is increased in women after a short period of tomato consumption. J. Nutri, 130:189-192.
42. Prasad K. N., Cole W. C., Hovland A. R., Prasad K. C., Nahreini .P, Kumar B., Edwards-Prasad J. and Andreatta C. P. (1999). Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biological rationale. Curr. Opin. Neurol., 12:761-770.
43. Rao A. V.and Balachandran B. (2002). Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutri. Neurosci., 5:291-309
44. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M. and Rice-Evans C.A. (1999). Antioxidant activity applying an improved ABTS radical cation decolourising assay. Free Radic. Biol. Med, 26: 1231-1237.
45. Rice-Evans C. A, Diplock A. T. (1993). Current status of antioxidant therapy. Free Rad. Biol. Med, 15:77-96.
46. Rice-Evans C. A., Miller N. J., Bolwell G. P., Bramley P. M. and Pridham J. B. (1995). The relative antioxidant activities of plat-derived polyphenolic favonoids. Free Radic. Res., 22:375-383
47. Singh R. P., Sharad S. and Kapur S. (2004). Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. J. Ind. Acad. Clin. Med. 5:218-225
48. Sofowora A. (1982). In: Medicinal Plants and traditional medicine in Africa. John Wiley and Sons. Chichester,UK.
49. Sun A. Y., Chen Y. (1998). Oxidative stress and neurodegenerative disorders. J. Biomed. Sci, 5:401-414.
50. Sun A. Y., Simonyi A., Sun G. Y. (2002). The “French Paradox”and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med., 32: 314-318 Bizimenyera et al., Afr. J. Trad. CAM (2007) 4 (1): 99 - 106
51. Takao T., Kitatani .F, Watanabe N., Yagi A. and Sakata K. (1994). A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish. Biosci. Biotech. Biochem,. 58: 1780-1783.
52. Thabrew M. I., Hughes R. D. and McFarlane I. G. (1998). Antioxidant activity of Osbeckia aspera. Phytother. Res., 12:288-290
53. Thompson A. (1997). As patients embrace herbal remedies, dearth of scientific evidence frustrates clinicians. Am. J. Health Syst. Pharm, 54:2656-2664.
54. Van der Merwe D. (2000). Use of ethnoveterinary medicine plants in cattle by Setwana-speaking people in the Madikwe area of the North West Province. M.Sc Dissertation. University of Pretoria. South Africa.
55. Van den Berg R, Haenen G. R. M. M., Van der Berg H. and Bast A. (1999). Application of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity of measurement of mixtures. Food Chem, 66:511-517.
56. Van Wyk B. E. and Gericke N. (2000). In: People"s plants. Briza Publications, Pretoria, pp. 130.
57. Van Wyk B E , Wink M (2004) In: Medicinal plants of the world. 1^st Ed ,2nd Revised impression. Briza. Pretoria.
58. Venter F. and Venter J. A. (1996). In: Making the most of Indigenous Trees. Briza publications.Pretoria, pg 20-21.
59. Viana M., Barbas C., Banet B., Bonet M. V., Castro M., Fraile M. U. and Herrela . (1996). In vitro effect of a flavonoid-rich extract on LDL oxidation. Athelosclerosis , 123: 83-91
60. Watt J. M. and Breyer-Brandwijk M. G. (1962) . The medicinal and poisonous plants of Southern and Eastern Africa. 2^nd Ed. E& S Livingstone. London , pp. 638.
61. Weiss R. F. and Fintelmann V. (2000). In: Herbal Medicine. 2^nd edition. Thieme. Stuttgart,pg. 3-20

© Copyright 2007 -African Journal of Traditional, Complementary and Alternative Medicines

The following images related to this document are available:

Photo images